The Ukrainian Medicine Agency Held a Meeting with Representatives of the Union of Ukrainian Entrepreneurs

Опубліковано 11.11.2026 о 17:01

On 11 November 2026, a working meeting with representatives of the Public Union “Union of Ukrainian Entrepreneurs” was held at the Ukrainian Medicine Agency.

Taras Proniv, Acting Head of the Ukrainian Medicine Agency, welcomed the participants and emphasised the importance of open communication between the state regulator and the business community. He also noted that the Agency is open to dialogue with business representatives. Taras Proniv stressed that the Agency’s specialists are ready to provide the necessary clarifications and assist pharmaceutical market participants in understanding the new requirements.

Representatives of the Ukrainian Medicine Agency answered questions and discussed how approaches to the activities of pharmaceutical market operators would change in the context of the implementation of new legislation governing the circulation of medicinal products, as well as practical aspects of future state regulation.

Particular attention was paid to the licensing of the manufacture, import and wholesale distribution of medicinal products, the organisation of pharmaceutical warehouse operations, and compliance with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) requirements.

The participants also discussed issues related to the manufacture, import and wholesale distribution of active pharmaceutical ingredients (APIs), including confirmation of manufacturers’ compliance with GMP requirements and the supporting documentation for such procedures.

Business representatives also received detailed answers regarding state quality control of medicinal products, laboratory testing and the requirements applicable to authorised laboratories.

The Ukrainian Medicine Agency thanks the participants for the constructive discussion and reaffirms its openness to continued dialogue with the business community. Such cooperation is important to ensure a consistent transition to the new regulatory framework without jeopardising the uninterrupted supply of quality medicinal products to the population.

 

Print button Версія для друку

Попередня

Deputy Head of the Ukrainian Medicine Agency Hanna Huseva Assumes Office